Perspective Therapeutics, Inc.
AMEXPerspective Therapeutics walks into tonight's Q1 earnings call with short sellers in an unusually aggressive posture — and the stock down 13% over the past month to $3.88. Short interest has climbed sharply. At nearly 18.6% of the free float, the position has grown 25% in a single month. The latest daily reading of 13.86 million shares is the highest in the 30-day window…
Snapshot as of 25 Jun 2026
Perspective Therapeutics walks into tonight's Q1 earnings call with short sellers in an unusually aggressive posture — and the stock down 13% over the past month to $3.88. Short interest has climbed sharply. At nearly…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CATX — free to start on ORTEX.
Sign up for free →Open CATX on ORTEX